Constitutive Activation of Guanylate Cyclase by the G86R GCAP1 Variant Is Due to "Locking" Cation-π Interactions that Impair the Activator-to-Inhibitor Structural Transition.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Jan 2020
Historique:
received: 09 12 2019
revised: 18 01 2020
accepted: 20 01 2020
entrez: 26 1 2020
pubmed: 26 1 2020
medline: 18 11 2020
Statut: epublish

Résumé

Guanylate Cyclase activating protein 1 (GCAP1) mediates the Ca

Identifiants

pubmed: 31979372
pii: ijms21030752
doi: 10.3390/ijms21030752
pmc: PMC7037459
pii:
doi:

Substances chimiques

Amino Acids, Aromatic 0
Cations 0
GUCA1A protein, human 0
Guanylate Cyclase-Activating Proteins 0
Recombinant Proteins 0
Guanylate Cyclase EC 4.6.1.2
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondazione Telethon
ID : GGP16010
Organisme : Deutsche Forschungsgemeinschaft
ID : GRK1885
Organisme : Deutscher Akademischer Austauschdienst
ID : to S.A.

Déclaration de conflit d'intérêts

The authors declare no conflict of interests.

Références

J Neurosci. 2004 Jul 7;24(27):6078-85
pubmed: 15240799
J Biol Chem. 2004 Apr 23;279(17):16903-6
pubmed: 14993224
ACS Chem Biol. 2015 Oct 16;10(10):2344-52
pubmed: 26204433
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1124-32
pubmed: 15790869
Cell Mol Life Sci. 2010 Mar;67(6):973-84
pubmed: 20213926
Biochemistry. 2002 Oct 29;41(43):13021-8
pubmed: 12390029
Genet Med. 2017 Aug;19(8):945-954
pubmed: 28125083
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):3863-70
pubmed: 15505030
Hum Mol Genet. 2018 Dec 15;27(24):4204-4217
pubmed: 30184081
Biochim Biophys Acta. 2005 Aug 10;1751(2):119-39
pubmed: 16027053
J Biol Chem. 2006 Aug 18;281(33):23830-41
pubmed: 16793776
ACS Chem Neurosci. 2013 Jun 19;4(6):909-17
pubmed: 23472635
J Biol Chem. 2012 Apr 20;287(17):13972-84
pubmed: 22383530
Eur J Biochem. 2003 Sep;270(18):3814-21
pubmed: 12950265
Orphanet J Rare Dis. 2007 Feb 01;2:7
pubmed: 17270046
Nanoscale. 2014 Dec 21;6(24):15037-47
pubmed: 25367003
Vision Res. 2008 Oct;48(23-24):2425-32
pubmed: 18706439
Prog Retin Eye Res. 2014 Sep;42:1-26
pubmed: 24857951
Anal Biochem. 2016 Feb 1;494:93-100
pubmed: 26617128
Mol Cell Biochem. 2010 Jan;334(1-2):117-24
pubmed: 19953307
Hum Mol Genet. 2015 Dec 1;24(23):6653-66
pubmed: 26358777
Chemistry. 2014 May 26;20(22):6756-62
pubmed: 24677478
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Biomed Res Int. 2013;2013:517570
pubmed: 24024198
Hum Mol Genet. 1998 Feb;7(2):273-7
pubmed: 9425234
Front Mol Neurosci. 2018 Nov 02;11:397
pubmed: 30450035
Surv Ophthalmol. 2006 May-Jun;51(3):232-58
pubmed: 16644365
Neurosci Lett. 2013 Apr 29;541:179-83
pubmed: 23428504
Mol Cell. 1998 Jul;2(1):129-33
pubmed: 9702199
Hum Mutat. 2009 Aug;30(8):E782-96
pubmed: 19459154
Biochim Biophys Acta. 2015 Sep;1853(9):2055-65
pubmed: 25447547
J Biol Chem. 2007 Jul 27;282(30):21645-52
pubmed: 17545152
Front Mol Neurosci. 2015 Nov 17;8:67
pubmed: 26635520
Mol Vis. 2005 Feb 20;11:143-51
pubmed: 15735604
Sci Rep. 2016 Oct 14;6:34277
pubmed: 27739433
Cell Mol Life Sci. 2014 Oct;71(19):3829-40
pubmed: 24566882
PLoS One. 2018 Mar 7;13(3):e0193947
pubmed: 29513743
J Biol Chem. 1998 Jul 10;273(28):17311-4
pubmed: 9651312
Front Mol Neurosci. 2018 Aug 17;11:274
pubmed: 30174586
Doc Ophthalmol. 2014 Feb;128(1):59-67
pubmed: 24352742
Mol Cell Biochem. 2010 Jan;334(1-2):105-15
pubmed: 19943184
Sci Rep. 2019 Oct 21;9(1):15058
pubmed: 31636333
Nanoscale. 2017 Aug 17;9(32):11773-11784
pubmed: 28785759
Mol Vis. 2017 Apr 03;23:198-209
pubmed: 28442884
Structure. 2007 Nov;15(11):1392-402
pubmed: 17997965
Prog Retin Eye Res. 2012 Sep;31(5):442-66
pubmed: 22658984
Hum Mol Genet. 2017 Jan 1;26(1):133-144
pubmed: 28025326
Biochemistry. 2013 Jul 30;52(30):5065-74
pubmed: 23815670
Am J Hum Genet. 2001 Sep;69(3):471-80
pubmed: 11484154
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
J Biol Chem. 2019 Mar 8;294(10):3476-3488
pubmed: 30622141
Nanoscale. 2014 Jan 7;6(1):412-23
pubmed: 24213152
Front Mol Neurosci. 2019 Mar 07;12:50
pubmed: 30899213
Front Mol Neurosci. 2014 Mar 17;7:19
pubmed: 24672427
Anal Chem. 2012 Mar 20;84(6):2982-9
pubmed: 22404528

Auteurs

Seher Abbas (S)

Department of Neuroscience, Division of Biochemistry, University of Oldenburg, 26111 Oldenburg, Germany.

Valerio Marino (V)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biological Chemistry, University of Verona, 37134 Verona, Italy.

Laura Bielefeld (L)

Department of Neuroscience, Division of Biochemistry, University of Oldenburg, 26111 Oldenburg, Germany.

Karl-Wilhelm Koch (KW)

Department of Neuroscience, Division of Biochemistry, University of Oldenburg, 26111 Oldenburg, Germany.

Daniele Dell'Orco (D)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biological Chemistry, University of Verona, 37134 Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH